menu search

Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in ...

November 3, 2023, 12:30 pm

Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller

Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expres...

October 31, 2023, 11:00 am

Sutro biopharma announces presentation of data for luveltamab tazevibulin (luvelta) from the phase 1 dose-expansion study in endometrial cancers at esmo 2023

– Luvelta demonstrated encouraging preliminary anti-tumor activity (29% response rate) in late-stage patients with recurrent/relapsed endometrial ca...

October 22, 2023, 8:25 am

Cytomx therapeutics presents preclinical profile of epcam-directed antibody drug conjugate cx-2051 at 2023 world adc conference

– CX-2051 is tailored for treatment of EpCAM-expressing cancers by matching target expression and tum...

October 18, 2023, 8:30 pm

Foghorn therapeutics to present clinical and pre-clinical data from multiple programs across its diverse pipeline at aacr-nci-eortc international conference

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a ne...

October 4, 2023, 8:00 am

Peloton and lululemon, does the deal make sense?

If you can't beat them, join them, right? It would not be too far-fetched to imagine that these were the last words spoken at Peloton NASDAQ: PTON and...

October 2, 2023, 8:31 am

American-style capitalism doesn't exist in france, guaranteeing low economic growth

People seldom think of Paris as an industrial city. There is too much about France's capital that is focused on love and leisure: wispy dreams evoke r...

September 29, 2023, 7:33 am

Weekend sip: this honey-flavored gin makes the perfect bee’s knees cocktail

Some of you may be familiar with the expression, “You’re the bee’s knees.” But what about the B...

September 23, 2023, 10:13 pm

Ncla asks u.s. supreme court to rein in qualified immunity for officials who violate speech rights

William Felkner v. John Nazarian, et al. Washington, D.C., Sept. 18, 2023 (GLOBE NEWSWIRE) — Invoking the contentious “qualified immunity” doctr...

September 18, 2023, 10:03 pm

Does revolut suffer from chatbot-based customer service?

The integration of technology has been a driving force behind innovation and ease in the dynamic domain of financial services. Chatbot-based customer ...

September 1, 2023, 7:17 am

Quiet before the storm, market participants brace for powell’s speech

The expression calm or quiet before the storm is precisely what market participants witnessed today in ...

August 24, 2023, 10:07 pm

Foghorn therapeutics: ifs, buts, and clinical holds

Foghorn Therapeutics Inc. stock has increased by 70% in the last 4 months after a clinical hold on their lead program was lifted. Foghorn's technology...

August 16, 2023, 5:08 pm

Electric royalties provides positive update on its royalty portfolio

Electric Royalties Ltd (TSX-V:ELEC, OTC:ELECF) has provided an update on activities since June 28, 2023, that pertain to its royalty portfolio.  On J...

August 15, 2023, 11:36 am

Ll flooring stock jumps 12% after company says it is ‘exploring alternatives' for itself

LL Flooring Holdings Inc.'s LL, -2.85% shares rallied more than 12% in the extended session Monday after the company formerly known as Lumber Liquidat...

August 14, 2023, 5:15 pm

Alias technologies launches befake — an innovative ai-driven mobile app challenging the social media authenticity status quo

Why Be Real When You Can Be Anything? SAN FRANCISCO, Aug. 09, 2023 (GLOBE NEWSWIRE) — Alias Technologies — a trailblazer in AI innovation — unve...

August 9, 2023, 7:03 pm

Foghorn therapeutics provides second quarter 2023 financial and corporate update

— Initiating FHD-286 combination study in AML in the third quarter of 2023 — Selective BRM, ARID1B, EP300, and CBP, targeting key regulators of ge...

August 4, 2023, 11:00 am

Protalix biotherapeutics to announce second quarter 2023 financial and business results on august 7, 2023

Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , July 31, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Amer...

July 31, 2023, 6:50 am

Dna stock alert: ginkgo bioworks moves forward with novo nordisk partnership

Ginkgo Bioworks (NYSE: DNA ) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk (NYSE: NVO ). These tw...

July 11, 2023, 10:22 am

Globex mining's quebec iron-vanadium royalty property receives expression of interest for potential $420m funding

Globex Mining Enterprises Inc shared some promising news about a Quebec mineral property in which it has an interest. In a statement, Globex said that...

July 6, 2023, 2:23 pm

Trilaciclib increases pool of memory t cells in the tumor microenvironment responsible for long term immune surveillance and efficacy

– Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microenvironment – – Trilacicli...

June 4, 2023, 11:13 am


Search within

Pages Search Results: